How Much Is Enough? The Continuing Debate on the Axillary Lymph Node Dissection in Breast Cancer

Veronica C Shim, MD, FACS


Spring 2007 - Volume 11 Number 2

Since the Halsted radical mastectomy was introduced in 1894,1 breast cancer treatment has undergone major changes. More than a century later, breast conserving surgery is now accepted in the treatment armamentarium of early breast cancer. However, the role of axillary lymph node dissection (ALND) in breast cancer treatment continues to be controversial. The persistent question in this debate is whether we should abandon axillary lymph node evaluation in breast cancer management; I believe we cannot.



27,000 print readers per quarter, 15,350 eTOC readers, and in 2018, 2 million page views of TPJ articles in PubMed from a broad international readership.


Indexed in MEDLINE, PubMed Central, HINARI, EMBASE, EBSCO Academic Search Complete, rdrb, CrossRef, and SciVerse/Scopus.


Click here to join the eTOC list or text TPJ to 22828. You will receive an Email notice with the Table of Contents of each issue.




ISSN 1552-5767 Copyright © 2019

All Rights Reserved.